<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR941205-1-00029</title>
	</head>
	<body>
		<main>
			<p><!-- PJG ITAG l=10 g=1 f=2 --> DATES: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Written comments by February 3, 1995. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> <!-- PJG STAG 4702 -->  <!-- PJG ITAG l=94 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=69 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=50 g=1 f=1 -->   <USDEPT>DEPARTMENT OF HEALTH AND HUMAN SERVICES</USDEPT>  <!-- PJG /ITAG -->  <!-- PJG ITAG l=18 g=1 f=1 -->  <USBUREAU>Food and Drug Administration</USBUREAU> <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=41 g=1 f=1 -->  <RINDOCK>21 CFR Part 184</RINDOCK> <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=52 g=1 f=1 --> [Docket No. 83G&hyph;0277] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=55 g=1 f=1 -->  <!-- PJG 0024 unknown --> -Amylase Enzyme Preparation; Affirmation of GRAS Status as Direct Human Food Ingredient <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <AGENCY> <!-- PJG ITAG l=10 g=1 f=2 --> AGENCY: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Food and Drug Administration, HHS. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </AGENCY> <ACTION> <!-- PJG ITAG l=10 g=1 f=2 --> ACTION: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Tentative final rule. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=59 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </ACTION> <SUMMARY> <!-- PJG ITAG l=10 g=1 f=2 --> SUMMARY: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  The Food and Drug Administration (FDA) is tentatively affirming that  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> -amylase enzyme preparation derived from  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=3 --> Bacillus <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->   <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=3 --> stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  is generally recognized as safe (GRAS) for use in the processing of starch to make maltodextrins and nutritive carbohydrate sweeteners. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->   <!-- PJG 0012 frnewline --> </SUMMARY> <DATE> <!-- PJG ITAG l=10 g=1 f=2 --> DATES: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Written comments by February 3, 1995. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </DATE> <ADDRESS> <!-- PJG ITAG l=10 g=1 f=2 --> ADDRESSES: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Submit written comments to the Dockets Management Branch (HFA&hyph;305), Food and Drug Administration, rm. 1&hyph;23, 12420 Parklawn Dr., Rockville, MD 20857. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </ADDRESS> <FURTHER> <!-- PJG ITAG l=10 g=1 f=2 --> FOR FURTHER INFORMATION CONTACT:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  <!-- PJG 0012 frnewline --> Vincent E. Zenger,  <!-- PJG 0012 frnewline --> Center for Food Safety and Applied Nutrition (HFS&hyph;206),  <!-- PJG 0012 frnewline --> Food and Drug Administration,  <!-- PJG 0012 frnewline --> 200 C St. SW.,  <!-- PJG 0012 frnewline --> Washington, DC 20204,  <!-- PJG 0012 frnewline --> 202&hyph;418&hyph;3105.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FURTHER> <SUPPLEM> <!-- PJG ITAG l=84 g=1 f=2 --> SUPPLEMENTARY INFORMATION:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> I. Background <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> In accordance with the procedures described in &sect;170.35 (21 CFR 170.35), CPC International Inc., International Plaza, Englewood Cliffs, NJ 07632, submitted a petition (GRASP 3G0284) requesting that  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase enzyme from  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> B <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> .  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  used in the production of nutritive saccharides from starch be affirmed as GRAS as a direct human food ingredient. The petition includes information about the identity of, and manufacturing processes for,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase enzyme preparations derived from  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> B <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> .  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> ; information about the history of human food use of  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase derived from  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> B <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> .  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> ; final reports and published articles of safety studies with  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase enzyme preparation derived from  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> B <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> .  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> ; and published literature with respect to  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase and bacterial  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase preparations. <!-- PJG 0012 frnewline --> FDA published a notice of the filing of this petition in the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=4 --> Federal Register <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  of September 21, 1983 (48 FR 43096). FDA gave interested persons an opportunity to submit comments to the Dockets Management Branch (address above). FDA did not receive any comments in response to that notice.  <!-- PJG 0012 frnewline --> In the filing notice the agency gave notice that the petition had requested that  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase enzyme derived from B. stearothermophilus be affirmed as GRAS for use in production of sweeteners from starch. However, the petition requested, and the agency evaluated, the use of this enzyme preparation in the production of nutritive saccharides (which includes maltodextrins as well as nutritive carbohydrate sweeteners). The end products of the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase hydrolysis of starch are maltodextrins, which are not sweet and are not used as sweeteners in food, as well as nutritive carbohydrate sweeteners. Maltodextrins may be used as a food ingredient or used as a raw material in the manufacture of nutritive carbohydrate sweeteners, for example, glucose syrups. Therefore, FDA finds that the phrase ``production of maltodextrins and nutritive carbohydrate sweeteners from starch'' is a more accurate description of the petitioned food use of  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase enzyme preparation. FDA is publishing this document as a tentative final rule to afford interested persons the opportunity to comment on this change. To avoid confusion between  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase, the enzyme, and  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase, the enzyme preparation (in which  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase is the principal active component, but which also contains other components derived from the production organism or the fermentation media), this document will use the term `` <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase'' to refer to the former and `` <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase enzyme preparation'' to refer to the latter. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> II. Standards for GRAS Affirmation <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Pursuant to &sect;170.30 (21 CFR 170.30), general recognition of safety may be based only on the views of experts qualified by scientific training and experience to evaluate the safety of substances. The basis of such views may be either: (1) Scientific procedures, or (2) in the case of a substance used in food prior to January 1, 1958, experience based on common use in food. General recognition of safety based upon scientific procedures requires the same quantity and quality of scientific evidence as is required to obtain approval of a food additive regulation and ordinarily is to be based upon published studies, which may be corroborated by unpublished studies and other data and information (&sect;170.30(b)). General recognition of safety through experience based on common use in food prior to January 1, 1958, may be determined without the quantity or quality of scientific procedures required for approval of a food additive regulation but ordinarily is to be based upon generally available data and information concerning its pre-1958 use (&sect;170.30(c)). <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> III. Safety Evaluation <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> A. Introduction <!-- PJG 0012 frnewline --> Starch produced in plants exists in two main forms. The linear form is composed of  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> -D-glucose sugar residues bonded together with a type of linkage termed  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> -1,4 (Ref. 1). This linear form is commonly termed amylose. The other form of starch, termed amylopectin, is composed of amylose molecules linked together at branch points. In this form, resembling a tree-like structure, the branch points are formed by a different kind of linkage termed  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> -1,6. An  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> -amylase enzyme (1,4- <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> -D glucan glucanohydrolase (International Union of Biochemistry Enzyme Commission (E.C.) 3.2.1.1)) can hydrolyze, i.e., break, the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> -1,4 linkages found in amylose and amylopectin (Ref. 2). Treatment with  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> -amylase enzyme lowers the molecular weight of the starch molecules to form molecules collectively called maltodextrins. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Certain maltodextrins may be subjected to subsequent processing. For instance, corn maltodextrins may be further hydrolyzed by another enzyme, glucoamylase, to produce glucose (also known as dextrose) which may in turn be isomerized to form high fructose corn syrups. These corn sweeteners are refined with ion exchange resins to remove impurities and are then concentrated. The processed corn sweeteners are then used in a wide variety of products in the food industry. Current technology sometimes requires the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase enzyme to function at high temperatures, up to 110 <!-- PJG 0017 degreeslatlong --> &cir; C (Refs. 1 and 3). Therefore, much effort has gone into research on  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylases from thermophilic microorganisms such as  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> B <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> .  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  (Ref. 3). <!-- PJG 0012 frnewline --> In evaluating this petition to affirm as GRAS the use of  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase enzyme preparation from  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> B <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> .  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  as a food ingredient, the agency considered six aspects of its manufacture and use: (1) The identity of the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase enzyme component; (2) the identity and safety of the source (production) organism for the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase enzyme preparation; (3) the manufacturing process of the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase enzyme preparation; (4) the intended uses for the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase enzyme preparation in food and exposure to residual levels of the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase enzyme preparation; (5) the specifications for the formulation of the enzyme preparation; and (6) toxicological studies of the enzyme preparation. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> B. The Enzyme Component <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase enzyme from  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> B <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> .  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  is extracellular (Ref. 2). That is, the enzyme is secreted by the bacteria into the surrounding media. Data and published information in the petition confirm that the petitioner's enzyme preparation from  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> B <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> .  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  functions in the hydrolysis of starch as an  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase (1,4- <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -D glucan glucanohydrolase (E.C. 3.2.1.1)) (Refs. 4 through 7). <!-- PJG 0012 frnewline --> Published data show that the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase enzyme functions at an optimum temperature of 80 <!-- PJG 0017 degreeslatlong --> &cir; C and at pH values below 6 (Ref. 7), which is consistent with previous published reports characterizing  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase from  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> B <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> .  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  and other thermophilic Bacillus species (Refs. 2 and 3). The published data further show that the petitioner's enzyme has a molecular weight of 58 kilodaltons (kd) (Ref. 7) which is consistent with the 58 kd mass reported by Sen (Ref. 8) and within experimental error of the predicted 61 kd mass based on deoxyribonucleic acid (DNA) sequence analysis (Ref. 9).  <!-- PJG 0012 frnewline --> The  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylases are functionally divided into two categories, saccharifying  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylases, which break approximately 40 to 60 percent of the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -1,4 linkages in a starch, and liquefying  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylases, which break only 30 to 40 percent of the linkages in the starch (Ref. 3). The  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase from  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> B <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> .  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  is of the liquefying type and is very similar in protein sequence to liquefying  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylases from other Bacillus species that have been commonly used in food processing (Refs. 1, 3, and 9 through 12), for example,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Bacillus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->   <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> amyloliquefaciens <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  (Ref. 1) and  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Bacillus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->   <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> licheniformis <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  (see 21 CFR 184.1027).  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> C. The Production Organism <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The source organism for this enzyme preparation is the bacterium  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> B <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> .  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> . The petition includes data to show that the strain used by the petitioner,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> B <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> .  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  (AS&hyph;154), conforms to the description of  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> B <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> .  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  in ``Bergey's Manual of Determinative Bacteriology,'' 8th ed. (Ref. 13), which is a standard compendium for the taxonomy of bacteria. The petition also contains data to show that this strain of  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> B <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> .  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  is an asporogenic variant and does not produce antibiotics or toxins. <!-- PJG 0012 frnewline --> Published scientific literature as well as standard textbooks on food microbiology demonstrate that  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> B <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> .  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  and its spores are widely distributed in nature and they are commonly found in fresh foods (Refs. 13 and 14).  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> B <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> .  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  is also reported to be the typical organism causing nontoxic sour spoilage in low acid foods (Ref. 14).  <!-- PJG 0012 frnewline --> The petition contains one published pathogenicity study that demonstrated that  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> B <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> .  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  is not pathogenic (Ref. 15). The petition also contains an extensive search of the published literature from 1917 to 1992 involving over 1,700 references and citations relating to  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> B <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> .  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  concerning pathogenicity, pathogen formation, toxicology and toxins, and disease or infection. The search failed to disclose a single report that implicated  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> B <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> .  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  as the etiologic agent of a disease state in man or animals. There were no reports of any toxicity or pathogenicity associated with the presence of this organism in food. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> D. The Manufacturing Process <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase enzymes of Bacillus are extracellular enzymes (Ref. 10). Therefore, the manufacturing procedures follow those generally used in the enzyme industry to separate and concentrate extracellular enzymes (Ref. 16). Under the method of manufacture of  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase enzyme preparation described in the petition,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> B <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> .  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  is maintained as a pure culture under conditions that minimize any genetic changes and is grown in a pure culture fermentation. When fermentation is complete, the broth is clarified by treating it with calcium hydroxide, and cells are removed from the broth by filtration using a diatomaceous earth filter aid (Ref. 17). The filtered, clarified broth containing the soluble enzyme is then ultrafiltered to remove all particulate matter. The filtrate, containing the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase enzyme, is then evaporated to a concentrate of the desired enzyme potency, usually about a three-fold concentration. Sodium chloride is added to the concentrate so that the final salt concentration is 20 percent by weight of the enzyme preparation. Data submitted in the petition show that the enzyme preparation produced by this method of manufacture does not contain any viable bacterial cells.  <!-- PJG 0012 frnewline --> FDA finds that the manufacturing method does not require the use of any processing materials that are not GRAS or approved food additives. Therefore, the agency concludes that the manufacturing steps will not introduce impurities into the enzyme preparation that will adversely affect the safety of the preparation. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> E. Estimated Exposure Levels <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The amount of the enzyme preparation used will vary based on the catalytic activity of the enzyme in any particular batch of enzyme preparation. Estimates of enzyme use level and intake are usually based on the total organic solids (TOS) content of the enzyme preparation (Ref. 18). TOS is the sum of all organic compounds present in the final enzyme preparation, excluding diluents or carriers, if added. TOS is calculated as follows: TOS percent=100-(A+W+D) where A is the percent of ash, W is the percent of water, and D is the percent of diluents or carriers.  <!-- PJG 0012 frnewline --> FDA's estimate of exposure to  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase enzyme preparation from  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> B <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> .  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  is based on the food use of maltodextrins and nutritive carbohydrate sweeteners, data for general usage of  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase preparations, and the relative enzymatic potency of this particular enzyme preparation compared to typical preparations. FDA calculates that the intake of typical  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase enzyme preparations reported as TOS is 25 milligrams (mg) TOS per person per day (TOS/person/day). The subject preparation has an enzymatic potency about six-fold higher than typical preparations; therefore, the estimated daily intake (EDI) is one-sixth of 25 mg or about 4 mg/TOS/person/day, or 67 micrograms (&mu;g)/kilograms (kg) body weight/day for a 60 kg person. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> F. Enzyme Preparation Specifications <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The petition contains data showing that the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase enzyme preparation from  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> B <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> .  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  produced in this manner meets the general and additional requirements for enzyme preparations in the ``Food Chemicals Codex,'' 3d ed. (Ref. 19). <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> G. Safety of Enzyme Preparation  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The petition contains published animal feeding studies to support the safety of the enzyme preparation. These include a 90-day subchronic oral toxicity study in dogs and a 90-day subchronic oral toxicity study in F1 rats exposed in utero. No adverse treatment-related effects were identified in the 90-day studies (Ref. 20). <!-- PJG 0012 frnewline --> The petition also contained several unpublished, corroborative safety studies. These animal feeding studies of the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase enzyme preparation included an acute oral toxicity study in rats and 14-day palatability studies in both rats and dogs. None of these studies demonstrated any adverse  <!-- PJG 0012 frnewline --> treatment-related effects.  <!-- PJG 0012 frnewline --> Based upon the 90-day dog study, FDA estimated an acceptable daily intake (ADI) of 377 &mu;g/kg body weight, which is 1/1000 of the highest no-effect level (377 mg/kg body weight, which was the highest dose tested). These studies show that the ADI for the enzyme preparation (377 &mu;g/kg body weight/day) exceeds the EDI for uses of this enzyme preparation (67 &mu;g/kg body weight/day). <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> IV. Conclusions  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The petition requested affirmation of GRAS status of  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase preparation from  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> B <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> .  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  based on its similarity to other  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase enzyme preparations that have a history of common use in food prior to 1958. The petition cites data that report that  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase enzyme preparation from B. subtilis has been used commercially since 1929, when it was used in the manufacture of chocolate syrup to reduce its viscosity (Ref. 21). The petition stated that bacterial  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase enzyme preparations were first described in the preparation of corn sweeteners in 1962, but that common use of these enzymes by major food processors did not occur until some time later. The petition also stated that today, corn sweeteners prepared with bacterial amylase enzyme preparations are used in nearly all commercially prepared foods. <!-- PJG 0012 frnewline --> The agency evaluated the petition using the criteria of &sect;170.30(c) and concluded that although  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase enzyme preparations have had a long history of use before 1958, the data provided no evidence for history of use of  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase enzyme preparation from  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> B <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> .  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> , and that based on the data in the petition, this preparation is not eligible for GRAS affirmation based on history of common use in food. However, the agency has also evaluated the petition using the criteria of &sect;170.30(b) and concludes that  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase enzyme preparation from  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> B <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> .  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  is eligible for GRAS affirmation based on scientific procedures. <!-- PJG 0012 frnewline --> The agency has evaluated the information in the petition along with other available information and concludes, based on evaluation of published information, corroborated by unpublished data and information, that use of the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase enzyme preparation derived by fermentation from  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> B <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> .  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  to hydrolyze starch to produce maltodextrins and nutritive carbohydrate sweeteners is GRAS. Furthermore, the data show no basis for a potential risk from any use of this  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase preparation that can be anticipated. Therefore, the agency is tentatively affirming that the use of the enzyme is GRAS with no limits other than current good manufacturing conditions in accordance with 21 CFR 184.1(b)(1).  <!-- PJG 0012 frnewline --> The agency further finds that because the principal active ingredient of the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase enzyme preparation is safe and because expected impurities in the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase enzyme preparation do not provide any basis for a safety concern that the general and additional requirements given for enzyme preparations in the ``Food Chemicals Codex,'' 3d ed. (1981), pp. 107-110, are adequate for defining minimum criteria for a food-grade  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase enzyme preparation derived from  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> B <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> .  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> . <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> V. Environmental Effects <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The agency has determined under 21 CFR 25.24(b)(7) that this action is of a type that does not individually or cumulatively have a significant effect on the human environment. Therefore, neither an environmental assessment nor an environmental impact statement is required. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> VI. Analysis of Impacts <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> FDA has examined the impacts of the tentative final rule under Executive Order 12866, and the Regulatory Flexibility Act (Pub. L. 96&hyph;354). Executive Order 12866 directs agencies to assess all costs and benefits of available regulatory alternatives and, when regulation is necessary, to select regulatory approaches that maximize net benefits (including potential economic, environmental, public health and safety, and other advantages; distributive impacts; and equity). The agency believes that this tentative final rule is consistent with the regulatory philosophy and principles identified in the Executive Order. In addition, the tentative final rule is not a significant regulatory action as defined by the Executive Order and so is not subject to review under the Executive Order.  <!-- PJG 0012 frnewline --> The Regulatory Flexibility Act requires agencies to analyze regulatory options that would minimize any significant impact of a rule on small entities. Because no current activity is prohibited by this tentative final rule, the compliance cost to firms is zero. Because no increase in the health risks faced by consumers will result from this tentative final rule, total costs are also zero. Potential benefits include the wider use of this enzyme because of reduced uncertainty concerning its GRAS status, and any resources saved by eliminating the need to prepare further petitions to affirm the GRAS status of this enzyme for this use. The agency certifies, therefore, that the tentative final rule will not have a significant economic impact on a substantial number of small entities. Therefore, under the Regulatory Flexibility Act, no further analysis is required. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> VII. References <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The following references have been placed on display in the Dockets Management Branch (address above) and may be seen by interested persons between 9 a.m. and 4 p.m., Monday through Friday. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> 1. MacAllister, R. V., ``Manufacture of High Fructose Corn Syrup Using Immobilized Glucose Isomerase,'' in ``Immobilized Enzymes for Food Processing,'' W. H. Pitcher, Jr., editor, CRC Press, Inc., Boca Raton, FL, pp. 81&hyph;111, 1980. <!-- PJG 0012 frnewline --> 2. Vihinen, M. and P. Mantsala, ``Microbial Amylolytic Enzymes,''  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> CRC Critical Reviews in Biochemistry and Molecular Biology <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> , 24:329&hyph;418, 1989. 3. Tomazic, S. J. and A. M. Klibanov, ``Mechanisms of Irreversible Thermal Inactivation of Bacillus  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> -Amylases,''  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Journal of Biological Chemistry <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> , 263:3086&hyph;3091, 1988. <!-- PJG 0012 frnewline --> 4. Tamuri, M. et al., ``Heat and Acid Stable  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> -Amylase Enzymes and Processes for Producing the Same,'' U.S. Patent No. 4,284,722, 1981. <!-- PJG 0012 frnewline --> 5. Brumm, P. J. and W. M. Teague, ``Effect of Additives on the Thermostability of  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Bacillus stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 -->   <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> -Amylase,'' Biotechnology Letters, 11:541&hyph;544, 1989. <!-- PJG 0012 frnewline --> 6. Henderson, W. E. and W. M. Teague, ``A Kinetic Model of  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Bacillus stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 -->   <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> -Amylase under Process Conditions,''  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Starch/Starke <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> , 40:412&hyph;418, 1988. <!-- PJG 0012 frnewline --> 7. Brumm, P. J. et al., ``Purification and Properties of a New Commercial, Thermostable  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Bacillus stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 -->   <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> -Amylase,''  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Food Biotechnology <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> , 2:67&hyph;80, 1988. <!-- PJG 0012 frnewline --> 8. Sen, S. and P. Oriel, ``Multiple Amylase Genes in Two Strains of  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Bacillus stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> ,''  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Gene <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> , 76:137&hyph;144, 1989. <!-- PJG 0012 frnewline --> 9. Ihara, H. et al., ``Complete Nucleotide Sequence of a Thermophilic  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> -Amylase Gene: Homology between Prokaryotic and Eukaryotic  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> -Amylases at the Active Sites,''  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Journal of Biochemistry <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> , 98:95&hyph;103, 1985. <!-- PJG 0012 frnewline --> 10. Suominen, I. et al., ``Extracellular Production of Cloned  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> -Amylase by Escherichia coli,''  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Gene <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> , 61:165&hyph;176, 1987. <!-- PJG 0012 frnewline --> 11. Tsukamoto, A. et al., ``Nucleotide Sequence of the Maltohexaose-Producing Amylase Gene from an Alkalophilic Bacillus sp. No. 707 and Structural Similarity to Liquefying Type  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> -Amylases,''  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Biochemical and Biophysical Research Communications <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> , 151:25&hyph;31, 1988. <!-- PJG 0012 frnewline --> 12. Satoh, H. et al., ``Evidence for Movement of the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> -Amylase Gene into Two Phylogenetically Distant  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Bacillus stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 -->  Strains,'' <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 -->  Journal of Bacteriology <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> , 170:1034&hyph;1040, 1988. <!-- PJG 0012 frnewline --> 13. ``Bergey's Manual of Determinative Bacteriology,'' 8th ed., Williams and Wilkins Co., Baltimore, p. 1135, 1975. <!-- PJG 0012 frnewline --> 14. Ito, K. A., ``Thermophilic Organisms in Food Spoilage: Flat-Sour Aerobes,''  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Journal of Food Protection <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> , 44:157&hyph;163, 1981. <!-- PJG 0012 frnewline --> 15. Sattar, S. A. et al., ``Hazard Inherent in Microbial Tracers: Reduction of Risk by the Use of  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Bacillus stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 -->  Spores in Aerobiology,''  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Applied Microbiology <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> , 23:1053&hyph;1059, 1972. <!-- PJG 0012 frnewline --> 16. Frost, G. M. and D. A. Moss, ``Production of Enzymes by Fermentation,'' in ``Biotechnology, Vol. 7A, Enzyme Technology,'' H. J. Rehm and G. Reed, editors, J. F. Kennedy, Vol. editor, VCH, New York, pp.72&hyph;76, 1987. <!-- PJG 0012 frnewline --> 17. Brummer, W. and G. Gunzer, ``Laboratory Techniques of Enzyme Recovery,'' in ``Biotechnology, Vol. 7A, Enzyme Technology,'' H. J. Rehm and G. Reed, editors, J. F. Kennedy, Vol. editor, VCH, New York, pp. 217&hyph;219 and 273, 1987. <!-- PJG 0012 frnewline --> 18.``The 1978 Enzyme Survey Summarized Data,'' National Research Council/National Academy of Sciences, Washington, DC; U.S. Department of Commerce, National Technical Information Service PB81-216897, 1981, pp. i-iii. <!-- PJG 0012 frnewline --> 19. Monograph on Enzyme Preparations, in ``Food Chemicals Codex,'' 3d ed., National Academy Press, Washington, DC, pp. 107&hyph;110, 1981.  <!-- PJG 0012 frnewline --> 20. MacKenzie, K. M. and S. R. W. Petsel, ``Subchronic Toxicity Studies in Dogs and In Utero Rats Fed Diets Containing  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Bacillus stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 -->   <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> -Amylase from a Natural or Recombinant DNA Host,''  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> Food and Chemical Toxicology <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> , 27:599&hyph;606, 1989. <!-- PJG 0012 frnewline --> 21. Reed, T., ``Enzymes in Food Processing,'' Academic Press, New York, p. 406, 1966. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> VIII. Comments <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> FDA is publishing this document as a tentative final rule to afford interested persons the opportunity to comment on the use of the enzyme preparations in the production of maltodextrins, which was not discussed in the filing notice. <!-- PJG 0012 frnewline --> Interested persons may, on or before February 3, 1995, submit to the Dockets Management Branch (address above) written comments regarding this tentative final rule. Two copies of any comments are to be submitted, except that individuals may submit one copy. Comments are to be identified with the docket number found in brackets in the heading of this document. Received comments may be seen in the office above between 9 a.m. and 4 p.m., Monday through Friday.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> List of Subjects in 21 CFR Part 184 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Food ingredients, Incorporation by reference.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Director, Center for Food Safety and Applied Nutrition, it is proposed that 21 CFR part 184 be amended as follows: <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=52 g=1 f=1 --> PART 184_DIRECT FOOD SUBSTANCES AFFIRMED AS GENERALLY RECOGNIZED AS SAFE1.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The authority citation for 21 CFR Part 184 continues to read as follows: <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=4 --> Authority: <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 -->  Secs. 201, 402, 409, 701 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321, 342, 348, 371). <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 2. New &sect;184.1012 is added to subpart B to read as follows: <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;184.1012  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> -Amylase enzyme preparation from  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=3 --> Bacillus stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> . <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (a)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -Amylase enzyme preparation is obtained from the culture filtrate that results from a pure culture fermentation of a nonpathogenic and nontoxicogenic strain of  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Bacillus stearothermophilus <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> . Its characterizing enzyme activity is  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -amylase (1,4- <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 -->  <!-- PJG 0024 unknown -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -D glucan glucanohydrolase (E. C. 3.2.1.1)).  <!-- PJG 0012 frnewline --> (b) The ingredient meets the general and additional requirements for enzyme preparations in the ``Food Chemicals Codex,'' 3d ed. (1981), pp. 107&hyph;110, which is incorporated by reference in accordance with 5 U.S.C. 552(a). Copies are available from the National Academy Press, 2101 Constitution Ave. NW., Washington, DC 20418, or available for inspection at the Office of the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=4 --> Federal Register <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> , 800 North Capitol St. NW., Suite 700, Washington, DC. <!-- PJG 0012 frnewline --> (c) In accordance with &sect;184.1(b)(1), the ingredient is used in food with no limitation other than current good manufacturing practices. The affirmation of this ingredient as GRAS as a direct human food ingredient is based upon the following current good manufacturing practice conditions of use: <!-- PJG 0012 frnewline --> (1) The ingredient is used as an enzyme, as defined in &sect;170.3(o)(9) of this chapter, in the hydrolysis of edible starch to produce maltodextrins and nutritive carbohydrate sweeteners. <!-- PJG 0012 frnewline --> (2) The ingredient is used at levels not to exceed current good manufacturing practices. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated: November 22, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SUPPLEM> <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> Fred R. Shank, <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Director, Center for Food Safety and Applied Nutrition. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;29731 Filed 12&hyph;2&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4160&hyph;01&hyph;F <!-- PJG /ITAG --> </BILLING>  <!-- PJG /STAG --></p>
		</main>
</body></html>
            